Difference between revisions of "Team:NTHU Formosa"

Line 2: Line 2:
 
<html>
 
<html>
  
−
 
+
<div class="column full_size">
−
 
+
<p>
 +
Autonomous cell reporter system for non-invasive real-time blood diagnosis
 +
     
 +
People around the world are growing awareness to their health condition. To monitor the health condition, a wide range of biomarkers-- special substances in the bloodstream representing the physiological and pathological states-- has been used in clinical diagnoses1. Blood test is one of the most common way for detecting biomarkers but it suffers from several inevitable drawbacks such as invasiveness, time-consuming procedure, demand for medical staff service, non real-time tracking and so on. These disadvantages may discourage people from the periodic medical checkup. Indeed, according to a survey (of 1862 samples) pulled by our team, nearly half of the participants took blood test less than once a five-year frequency (Fig. 1), which is impractical for early detection and early treatment of diseases.
 +
In terms of non-invasive real-time health monitoring, great varieties of wearable devices and smartwatches, working as personal daily fitness trackers, have been developed. The global market of wearable medical devices is estimated to reach $35 billion USD soon. However, most of the current devices are only capable of measuring heart rate, steps taken, calories, quality of sleep and a few other personal metrics. These limited diagnosis information provided by current devices cannot precisely represent the physiological states relating to many diseases. To address this long-standing worldwide issue, we aim to develop a new tool, a non-invasive or minimally-invasive real-time tracking system for the level of specific biomarkers in bloodstream.
 +
</p>
 +
<img src="https://static.igem.org/mediawiki/2018/3/30/T--NTHU_Formosa--vote.png" height="156" width="305">
 +
</div>
  
 
<div class="column full_size" >
 
<div class="column full_size" >
Line 12: Line 19:
 
<img src="http://placehold.it/1080x320/c4baba/e4dede">
 
<img src="http://placehold.it/1080x320/c4baba/e4dede">
  
−
</div>
 
−
 
−
 
−
<div class="column full_size">
 
−
<p>
 
−
Autonomous cell reporter system for non-invasive real-time blood diagnosis
 
−
     
 
−
People around the world are growing awareness to their health condition. To monitor the health condition, a wide range of biomarkers-- special substances in the bloodstream representing the physiological and pathological states-- has been used in clinical diagnoses1. Blood test is one of the most common way for detecting biomarkers but it suffers from several inevitable drawbacks such as invasiveness, time-consuming procedure, demand for medical staff service, non real-time tracking and so on. These disadvantages may discourage people from the periodic medical checkup. Indeed, according to a survey (of 1862 samples) pulled by our team, nearly half of the participants took blood test less than once a five-year frequency (Fig. 1), which is impractical for early detection and early treatment of diseases.
 
−
In terms of non-invasive real-time health monitoring, great varieties of wearable devices and smartwatches, working as personal daily fitness trackers, have been developed. The global market of wearable medical devices is estimated to reach $35 billion USD soon. However, most of the current devices are only capable of measuring heart rate, steps taken, calories, quality of sleep and a few other personal metrics. These limited diagnosis information provided by current devices cannot precisely represent the physiological states relating to many diseases. To address this long-standing worldwide issue, we aim to develop a new tool, a non-invasive or minimally-invasive real-time tracking system for the level of specific biomarkers in bloodstream.
 
−
</p>
 
 
</div>
 
</div>
−
 
−
<img src="https://static.igem.org/mediawiki/2018/3/30/T--NTHU_Formosa--vote.png" height="156" width="305">
 
  
 
<!-- <div class="column full_size" >
 
<!-- <div class="column full_size" >

Revision as of 21:13, 28 June 2018

Autonomous cell reporter system for non-invasive real-time blood diagnosis People around the world are growing awareness to their health condition. To monitor the health condition, a wide range of biomarkers-- special substances in the bloodstream representing the physiological and pathological states-- has been used in clinical diagnoses1. Blood test is one of the most common way for detecting biomarkers but it suffers from several inevitable drawbacks such as invasiveness, time-consuming procedure, demand for medical staff service, non real-time tracking and so on. These disadvantages may discourage people from the periodic medical checkup. Indeed, according to a survey (of 1862 samples) pulled by our team, nearly half of the participants took blood test less than once a five-year frequency (Fig. 1), which is impractical for early detection and early treatment of diseases. In terms of non-invasive real-time health monitoring, great varieties of wearable devices and smartwatches, working as personal daily fitness trackers, have been developed. The global market of wearable medical devices is estimated to reach $35 billion USD soon. However, most of the current devices are only capable of measuring heart rate, steps taken, calories, quality of sleep and a few other personal metrics. These limited diagnosis information provided by current devices cannot precisely represent the physiological states relating to many diseases. To address this long-standing worldwide issue, we aim to develop a new tool, a non-invasive or minimally-invasive real-time tracking system for the level of specific biomarkers in bloodstream.

Welcome to iGEM 2018!

Your team has been approved and you are ready to start the iGEM season!